Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Drug Discovery: Overview01:26

Drug Discovery: Overview

Drug discovery is a multifaceted process involving extensive screening, testing, and optimization of lead compounds to identify potential new drugs for therapeutic use. It combines several approaches, including screening large numbers of natural products, chemical modification of known active molecules, identification of new drug targets, and rational design based on biological mechanisms and drug-receptor structure. These approaches are carried out in both academic research laboratories and...
Drug Regulation01:25

Drug Regulation

Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

GATA2 mutation is associated with immune dysfunction and increased Mycobacterium haemophilum susceptibility in immunocompromised individuals.

JCI insight·2025
Same author

Leveraging Bluetooth low-energy technology to improve contact tracing among healthcare personnel in hospital setting during the coronavirus disease 2019 (COVID-19) pandemic.

Infection control and hospital epidemiology·2023
Same author

Mycobacterium haemophilum Related Myelitis in Geographically Linked Cases.

Annals of neurology·2023
Same author

Spatial Epidemiologic Analysis and Risk Factors for Nontuberculous Mycobacteria Infections, Missouri, USA, 2008-2019.

Emerging infectious diseases·2023
Same author

Genomic Analyses of Longitudinal Mycobacterium abscessus Isolates in a Multicenter Cohort Reveal Parallel Signatures of In-Host Adaptation.

The Journal of infectious diseases·2023
Same author

Missed Opportunities in the Diagnosis of Tuberculosis Meningitis.

Open forum infectious diseases·2023

Related Experiment Video

Updated: Jun 28, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Natural language processing to identify adverse drug events.

Michael Gysbers1, Richard Reichley, Peter M Kilbridge

  • 1BJC HealthCare, Center for Healthcare Quality & Effectiveness; Washington University School of Medicine, St. Louis, MO, USA.

AMIA ... Annual Symposium Proceedings. AMIA Symposium
|November 13, 2008
PubMed
Summary

We adapted a natural language processing tool (NLP) called caTIES to identify adverse drug events (ADEs). This method successfully detected ADEs across various document types, not just pathology reports.

Related Experiment Videos

Last Updated: Jun 28, 2026

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions
07:40

A Data Integration Workflow to Identify Drug Combinations Targeting Synthetic Lethal Interactions

Published on: May 27, 2021

Area of Science:

  • Biomedical Informatics
  • Natural Language Processing
  • Pharmacovigilance

Background:

  • Adverse Drug Events (ADEs) pose a significant public health challenge.
  • Accurate identification of ADEs is crucial for patient safety and drug development.
  • Existing methods for ADE detection may have limitations in scope or efficiency.

Purpose of the Study:

  • To evaluate the Cancer Text Information Extraction System (caTIES) for identifying terms related to ADEs.
  • To determine if caTIES, originally designed for pathology reports, can be adapted for broader ADE surveillance.
  • To assess the efficacy of a natural language processing (NLP) tool in a pharmacovigilance context.

Main Methods:

  • Utilized caTIES, a publicly available NLP tool.
  • Adapted caTIES for the specific task of detecting ADE-related terminology.
  • Tested caTIES on a diverse range of documents beyond its original scope (surgical pathology reports).

Main Results:

  • caTIES was successfully adapted for identifying terms suggestive of ADEs.
  • The NLP tool demonstrated effectiveness in searching for ADEs across a wider variety of documents.
  • The study confirms the adaptability of caTIES for broader applications in pharmacovigilance.

Conclusions:

  • The Cancer Text Information Extraction System (caTIES) is a viable NLP tool for identifying adverse drug events (ADEs).
  • caTIES's utility extends beyond surgical pathology reports, offering a flexible approach to ADE surveillance.
  • This adaptation highlights the potential of NLP tools in enhancing pharmacovigilance efforts.